5-year outcomes of patients with mitral structural valve deterioration treated with transcatheter valve in valve implantation

نویسندگان

چکیده

Abstract The Valve-in-Valve (ViV) technique is an emerging alternative for the treatment of bioprosthetic structural valve deterioration (SVD) in mitral position. We report on intermediate-term outcomes patients with symptomatic SVD position who were treated by transcatheter valve-in-valve (TM-ViV) implantation during years 2010–2019 our center. Three main examined follow-up period: NYHA functional class, TM-ViV hemodynamic data per echocardiography, and mortality. Our cohort consisted 49 (mean age 77.4±10.5 years, 65.3% female). indications mainly regurgitant pathology (77.6%). All a balloon-expandable device. procedure was performed via transapical access 17 cases (34.7%) transfemoral vein / trans-atrial septal puncture 32 (65.3%). Mean 4.4±2.0 years. 98% 91% I/II at 1 5 respectively. Mitral regurgitation ≥ moderate 86.3% prior to this decreased 0% (p<0.001) following maintained over 2 follow-up. mean trans-mitral gradients from pre-procedural values 10.1±5.1mmHg 7.0±2.4mmHg one month (p=0.03). Mortality year 16% (95%, CI 5–26) 35% 18–49) ViV offers effective durable option high surgical risk. Funding Acknowledgement Type funding sources: None.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transcatheter Mitral Valve Implantation

T he rationale for the development of a transcatheter mitral valve implantation (tMVI) procedure, either percutaneous or via minimally invasive surgery (MIS), arose from consideration of several key surgical concepts. First, mitral valve replacement is the most effective modality and the gold standard procedure for reliably reducing mitral regurgitation (MR). The efficacy and risks of mitral va...

متن کامل

Failed valve-in-valve transcatheter mitral valve implantation.

A 73-year old man underwent trans-septal anterograde implantation of a 26-mm Sapien-XT valve (Edwards Lifesciences, CA, USA) to treat a degenerated 27-mm Carpentier-Edwards bioprosthesis. During the follow-up, the patient experienced severe haemolysis with moderate-to-severe inter-valvular leak, and fluoroscopy revealed possible incomplete apposition of the Sapien-XT (Fig. 1). Reoperation was p...

متن کامل

Echocardiography in Transcatheter Aortic Valve Implantation and Mitral Valve Clip

Transcatheter aortic valve implantation and transcatheter mitral valve repair (MitraClip) procedures have been performed worldwide. In this paper, we review the use of two-dimensional and three-dimensional transesophageal echo for guiding transcatheter aortic valve replacement and mitral valve repair.

متن کامل

Transcatheter transapical valve-in-valve implantation for degenerated mitral bioprosthesis

A 76-year-old woman with a history of aortic and mitral valve (Mosaic 19 mm; Hancock II 25 mm bioprosthesis, Medtronic Inc., Minneapolis, Minnesota) replacement and former coronary artery bypass grafting in 2010 (left internal mammary artery-left anterior descending artery (LIMA-LAD), aorta-obtuse marginal coronary artery (Ao-OM)) was admitted to our hospital with recurrent pulmonary edema. Her...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal

سال: 2022

ISSN: ['2634-3916']

DOI: https://doi.org/10.1093/eurheartj/ehac544.2113